期刊文献+

曲古菌素A对多发性骨髓瘤细胞增殖影响的相关研究

The Effets of TSA in Rgulating Cell Proliferation and Apoptosis of Multiple Myeloma KM3 Cells
下载PDF
导出
摘要 目的:研究VEGF受体(Vascular endothelial growth factor receptor,VEGFR)在多发性骨髓瘤KM3细胞株中的表达及曲古菌素A(Trichostatin A,TSA)对KM3细胞增殖的影响,并进一步探讨其抗肿瘤机制。方法:体外培养KM3细胞株,MTT检测细胞增殖,流式细胞术检测细胞凋亡,RT-PCR检测VEGFR m RNA表达。结果:TSA能明显抑制KM3细胞的增殖,且具有时间剂量依赖性(P<0.05)的特点;TSA处理KM3细胞48h可诱导KM3细胞凋亡,凋亡率最高达42.72%±4.61%,呈剂量依赖性(P<0.05)特点;RT-PCR结果显示,KM3细胞仅表达VEGFR-1(flt-1),TSA能在m RNA水平抑制VEGFR-1的表达。结论:TSA可通过下调骨髓瘤细胞株KM3细胞表面VEGFR的表达,从而诱导KM3细胞的凋亡,而达到抑制其增殖的目的。 Objective:Despite of the recent advances in the treatment of multiple myeloma(MM),it is still an incurable disease in the majority of patients.In the bone marrow microenvironment of MM,VEGF is essential for tumor growth and survival,and myeloma cells are known to produce VEGF and express VEGF receptors.To investigate the effects of TSA(trichostatin A,TSA)in regulating VEGFR(vascular endothelial growth factor receptor)expression in multiple myeloma KM3cells,and study the antiproliferation mechanism of TSA on KM3cells.Methods:The cell proliferation was measured by MTT assay.The apoptosis rates were determined by flow cytometry.The mRNA level of VEGFR was determined by RT-PCR;immunocytochemistry was used to detect the protein level of VEGFR.Results:The proliferation of KM3cells decreased in TSA-treated groups in a time-dose dependent manner(P<0.05).Treatment with TSA(400、200、100and50ng·mL-1)for48h,the apoptosis rates of KM3cells were(11.77±4.64)%、(22.13±1.20)%、(23.95±.2.57)%and(42.72±4.61)%respectively.Only VEGFR-1(flt-1)was detected in KM3cells by RT-PCR and it was decreased in TSA-treated groups in a dose-dependent manner(P<0.05).Conclusion:TSA plays an important role in regulating proliferation and apoptosis of multiple myeloma cell line KM3cells,and this effect may be partly caused by decreasing the expression of VEGFR in KM3cells.
作者 张卉 董喜凤 ZHANG Hui;DONG Xi-feng(Department of Pharmacy, Tianjin Medical University Affiliated Stomatology Hospital, Tianjin 300070, China;Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300054, China)
出处 《药品评价》 CAS 2017年第16期27-30,共4页 Drug Evaluation
关键词 曲古菌素A 多发性骨髓瘤 血管内皮生长因子受体 凋亡 TSA Multiple Myeloma Vascular Endothelial Growth Factor Apoptosis
  • 相关文献

参考文献1

二级参考文献19

  • 1Carey N,La Thangue NB.Histone deacetylase inhibitors:gathering pace[J].Curr Opin Pharmacol,2006,6(4):369-375.
  • 2Glozak MA,Sengupta N,Zhang X,Seto E.Acetylation and deacetylation of non-histone proteins[J].Gene,2005,363:15-23.
  • 3Shukla PK,Tikoo KB.Histone deacetylase inhibitor inhibitors as therapeutic target[J].Curr Res Inform Pharmaceut Sci,2004,5(1):9-18.
  • 4Rosato RR,Maggio SC,Almenara JA,Payne SG,Atadja P,Spiegel S,et al.The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation,oxidative injury,and the acid sphingomyelinase-dependent generation of ceramide[J].Mol Pharmacol,2006,69(1):216-225.
  • 5Duan H,Heckman CA,Boxer LM.Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas[J].Mol Cell Biol,2005,25(5):1608-1619.
  • 6Xu Y,Voelter-Mahlknecht S,Mahlknecht U.The histone deace-tylase inhibitor suberoylanilide hydroxamic acid down-regulates expression levels of Bcr-abl,c-Myc and HDAC3 in chronic myeloid leukemia cell lines[J].Int J Mol Med,2005,15(1):169-172.
  • 7Hu J,Colburn NH.Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding[J].Mol Cancer Res,2005,3(2):100-109.
  • 8Guo F,Sigua C,Tao J,Bali P,George P,Li Y,et al.Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells[J].Cancer Res,2004,64(7):2580-2589.
  • 9Nebbioso A,Clarke N,Voltz E,Germain E,Ambrosino C,Bontempo P,et al.Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells[J].Nat Med,2005,11(1):77-84.
  • 10Qiu L,Burgess A,Fairlie DP,Leonard H,Parsons PG,Gabrielli BG.Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells[J].Mol Biol Cell,2000,11(6):2069-2083.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部